Research collaborations
Garvan drives a number of collaborative programs with scientific and medical institutes globally.
CIRCA
The Clinical Immunogenomics Research Consortium Australasia uses genomics to inform diagnosis and treatment for complex immunological diseases
OCCAMS
A multidisciplinary team investigating the link between MS and the Epstein-Barr virus.
Australian Parkinson's Mission
A five-year, international collaborative program for Parkinson’s disease, integrating clinical trials with potentially transformative genomic analysis and biomarkers research.
Hope Research
A radical program to understand autoimmune disease. Our researchers think there may be a common cause to type 1 diabetes, multiple sclerosis, lupus and rheumatoid arthritis.
Exceptional Responders Program
A collaborative study of those who have exceptional responses to cancer treatment — and using this knowledge to help others with the disease.